Gilead is now waiting for regulatory decisions on the twice-yearly PrEP in Europe and other markets, including South Africa ...

The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that ...

WASHINGTON (AP) — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, maker Gilead Sciences announced ...

The drug could change the course of the AIDS epidemic. But the Trump administration has gutted the programs that might have paid for it in low-income countries.

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...

With a Sh31 billion funding gap due to the pulling out of support from major donors, the government was expected to step up.

Without US funding as leverage, one of Uganda’s most prominent LGBT+ activists Steven Kabuye tells Rachel Schraer, there are ...

Dr Oluga said nearly 6,000 new HIV infections were recorded among individuals aged 15 to 24 which is troubling.

Through fresh measures and campaigns, the agency is engaging a broader range of stakeholders and addressing emerging trends that hinder progress in the fight.These new initiatives are actively ...